- Home
- GMED vs BRKR Comparison
GMED vs BRKR Comparison
Compare GMED & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMED
- BRKR
- Stock Information
- Founded
- GMED 2003
- BRKR 1960
- Country
- GMED United States
- BRKR United States
- Employees
- GMED N/A
- BRKR N/A
- Industry
- GMED Medical/Dental Instruments
- BRKR Biotechnology: Laboratory Analytical Instruments
- Sector
- GMED Health Care
- BRKR Industrials
- Exchange
- GMED Nasdaq
- BRKR Nasdaq
- Market Cap
- GMED 8.1B
- BRKR 6.3B
- IPO Year
- GMED 2012
- BRKR 2000
- Fundamental
- Price
- GMED $59.17
- BRKR $42.13
- Analyst Decision
- GMED Buy
- BRKR Buy
- Analyst Count
- GMED 13
- BRKR 12
- Target Price
- GMED $94.30
- BRKR $54.50
- AVG Volume (30 Days)
- GMED 1.2M
- BRKR 2.3M
- Earning Date
- GMED 08-05-2025
- BRKR 08-05-2025
- Dividend Yield
- GMED N/A
- BRKR 0.47%
- EPS Growth
- GMED 145.70
- BRKR N/A
- EPS
- GMED 1.34
- BRKR 0.52
- Revenue
- GMED $2,510,810,000.00
- BRKR $3,446,100,000.00
- Revenue This Year
- GMED $15.47
- BRKR $6.43
- Revenue Next Year
- GMED $8.97
- BRKR $4.21
- P/E Ratio
- GMED $44.29
- BRKR $80.87
- Revenue Growth
- GMED 32.26
- BRKR 14.84
- 52 Week Low
- GMED $54.48
- BRKR $34.10
- 52 Week High
- GMED $94.93
- BRKR $72.94
- Technical
- Relative Strength Index (RSI)
- GMED 46.02
- BRKR 63.12
- Support Level
- GMED $57.79
- BRKR $40.71
- Resistance Level
- GMED $61.29
- BRKR $43.21
- Average True Range (ATR)
- GMED 1.29
- BRKR 1.70
- MACD
- GMED 0.41
- BRKR 0.37
- Stochastic Oscillator
- GMED 53.10
- BRKR 87.46
About GMED Globus Medical Inc.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.